Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CellectisRubius TherapeuticsOsiris TherapeuticsAVITA MED LTD/SProteon Therapeutics
SymbolNASDAQ:CLLSNASDAQ:RUBYOTCMKTS:OSIROTCMKTS:AVMXYNASDAQ:PRTO
Price Information
Current Price$8.21$4.25$18.99$7.89$24.25
52 Week RangeHoldHoldN/ABuyHold
Analyst Ratings
Consensus RecommendationHoldHoldN/ABuyHold
Consensus Price Target$34.75$10.00N/A$10.00N/A
% Upside from Price Target323.26% upside135.29% upsideN/A26.74% upsideN/A
Trade Information
Market Cap$365.49 million$357.43 million$655.69 million$651.87 million$510.12 million
Beta1.932.12N/A1.280.6
Average Volume168,922456,755202,293183,2751,113,217
Sales & Book Value
Annual Revenue$22.99 millionN/AN/A$5.51 millionN/A
Price / Sales15.16N/AN/A118.31N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$8.37 per share$3.44 per shareN/A$0.26 per share($0.06) per share
Price / Book0.98N/AN/A30.35N/A
Profitability
Net Income$-102,090,000.00$-163,460,000.00N/A$-24,750,000.00$-20,730,000.00
EPS($2.41)($2.08)N/A($0.39)($1.15)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-444.90%N/AN/AN/AN/A
Return on Equity (ROE)-25.89%-50.42%N/AN/AN/A
Return on Assets (ROA)-20.74%-38.31%N/AN/A-118.68%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.13%0.32%N/AN/AN/A
Current Ratio6.25%8.57%N/A5.50%5.98%
Quick Ratio6.21%8.57%N/A5.33%5.98%
Ownership Information
Institutional Ownership Percentage31.15%N/A0.28%0.01%23.03%
Insider Ownership Percentage16.41%58.40%43.40%N/A45.70%
Miscellaneous
Employees161142N/A5517
Shares Outstanding42.45 million80.32 million34.53 million82.62 million22.18 million
Next Earnings Date5/5/2020 (Estimated)5/20/2020 (Estimated)N/AN/A5/6/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel